Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
07 Feb 2025 |
On P&L |
The Company informs on some of the results expected by the market consensus
|
Download |
|
07 Nov 2024 |
On P&L |
The Company releases the press release related to the first nine months 2024 financial results
|
Download |
|
07 Nov 2024 |
On P&L |
The Company releases the first nine months 2024 financial results presentation
|
Download |
|
24 Oct 2024 |
On corporate transactions |
ROVI completes the strategic review of its CDMO business
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2024 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
07 Jan 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the fourth quarter of 2024
|
Download |
|
07 Nov 2024 |
On P&L |
A correction to the English version of a document is reported.
|
Download |
|
03 Oct 2024 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the third quarter of 2024
|
Download |
|
12 Sep 2024 |
Other relevant information |
The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
06 Apr 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the first quarter of 2017
|
Download |
|
13 Mar 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to its biosimilar of Enoxaparin
|
Download |
|
07 Mar 2017 |
Otros sobre negocio y situación financiera |
ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome
|
Download |
|
16 Feb 2017 |
Otros sobre Gobierno Corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
16 Feb 2017 |
Informe anual de remuneraciones de los consejeros |
ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors
|
Download |
Pages
